Venetoclax/Obinutuzumab Continues to Show Efficacy in Unfit Patients with CLL
June 30th 2022An updated safety and efficacy analysis of the ongoing CLL14 trial showed that venetoclax plus obinutuzumab continues to be an effective treatment for patients with chronic lymphocytic leukemia and coexisting conditions.
Implementation of Individualized Pain Management in Vaso-occlusive Pain Crisis
June 25th 2022Utilization of specialty nurse practitioner driven teams and use of individualized pain protocols for patients admitted with vaso-occlusive pain crisis improves quality of life for patients with sickle cell disease, and decreased hospital stay times.
5-Year Survival Data Showcases Long-Term Benefit With Nivolumab/Ipilimumab-Treated Metastatic NSCLC
June 12th 2022Frontline nivolumab and ipilimumab combination therapy was associated with increased 5-year survivorship in patients with metastatic non–small cell lung cancer—regardless of PD-L1 expression.
Bioimpedance Spectroscopy Is a Better Predictor of Chronic Lymphedema Vs Tape Measurement
February 6th 2022Patients who underwent surveillance with bioimpedance spectroscopy were less likely to develop chronic breast cancer–related lymphedema compared with patients who were assessed with tape measure.
Geriatric Assessments Help Promote Comorbidity-Related Discussions in Patients With Advanced Cancer
January 28th 2022A secondary analysis of the COACH study revealed that a geriatric assessment–guided intervention increased the number of comorbidity-related discussions between patients and providers.